Skip to main content
. 2021 Apr 10;2021:6634253. doi: 10.1155/2021/6634253

Table 2.

Frequencies of lncRNA GAS5 genotypes and alleles in IS patients and controls.

Genotypes IS patients, n = 1086 (%) Controls, n = 1045 (%) AOR (95% CI) P value P valuea
rs145204276
ins/ins(II) 424 (39.0) 486 (46.5) 7.3 × 10−4 0.0020
ins/del(ID) 528 (48.6) 465 (44.5)
del/del(DD) 134 (12.3) 94 (9.0)
 Dominant model DD+ID vs. II 662 (61.0) 559 (53.5) 1.36 (1.14-1.61) 5.0 × 10−4 0.0020
 Recessive model II+ID vs. DD 952 (87.7) 951 (91.0) 0.70 (0.53-0.93) 0.013 0.026
ins allele 1376 (63.4) 1437 (68.8)
del allele 796 (36.6) 653 (31.2) 1.27 (1.12-1.45) 2.0 × 10−4 0.0016
rs55829688
 TT 579 (53.3) 517 (49.5) 0.20 0.23
 TC 415 (38.2) 430 (41.1)
 CC 92 (8.5) 98 (9.4)
 Dominant model TC+CC vs. TT 507 (46.7) 528 (50.5) 0.86 (0.72-1.02) 0.076 0.12
 Recessive model TT+TC vs. CC 994(91.5) 947(90.6) 1.12(0.83-1.51) 0.46 0.46
 T allele 1573(72.9) 1464(70.0)
 C allele 599(27.1) 626(30.0) 0.89(0.78-1.02) 0.087 0.12

P value of difference in genotypes between the case group and control group. P < 0.05 is indicated in bold font. Adjusted for age, gender, smoking, hypertension, diabetes mellitus, and hyperlipidaemia. aFalse discovery rate-adjusted P value for multiple hypotheses testing using the Benjamini-Hochberg method. AOR: adjusted odds ratio; CI: confidence interval; DD: del/del; ID: ins/del; II: ins/ins; IS: ischemic stroke; lncRNA: long noncoding RNA.